000286228 001__ 286228
000286228 005__ 20240229155123.0
000286228 0247_ $$2doi$$a10.11588/FMK.2023.23.100566
000286228 037__ $$aDKFZ-2023-02726
000286228 041__ $$aEnglish
000286228 1001_ $$0P:(DE-He78)85715ba619c4d7ffa8455b3320ffe1ed$$aJungkunz, Martin$$b0$$udkfz
000286228 1112_ $$aProjektgruppe EURAT Ethische und rechtliche Aspekte  der Translationalen Medizin
000286228 245__ $$aPosition paper on the return of additional genetic findings in minors
000286228 260__ $$aHeidelberg, Deutschland$$bForum Marsilius-Kolleg, NCT$$c2023
000286228 300__ $$a130 pages
000286228 3367_ $$2BibTeX$$aBOOK
000286228 3367_ $$0PUB:(DE-HGF)3$$2PUB:(DE-HGF)$$aBook$$bbook$$mbook$$s1702645812_27017
000286228 3367_ $$0PUB:(DE-HGF)26$$2PUB:(DE-HGF)$$aProceedings$$mproc
000286228 3367_ $$2DataCite$$aOutput Types/Book
000286228 3367_ $$2ORCID$$aBOOK
000286228 3367_ $$01$$2EndNote$$aBook
000286228 3367_ $$2DRIVER$$abook
000286228 500__ $$aForum Marsilius-Kolleg, Bd. 23 (2023): Stellungnahme zur Rückmeldung genetischer Zusatzbefunde Minderjähriger Heidelberg : Forum Marsilius-Kolleg Veröffentlicht 2023-10-30 /  [10.11588/FMK.2023.23.100566]
000286228 520__ $$aIn modern medicine, particularly in the fields of oncology and rare diseases, genetic diagnostics has become increasingly important in recent years. Steady progress in sequencing technology and consequently decreasing costs now allow exploratory testing using large gene panels and even whole genome sequencing. These methods offer great potential for more refined and faster diagnosis. At the same time, however, the large amount of data generated increases the likelihood that, in addition to the primary health-related information sought (primary findings), other genetic changes relevant to future health will be discovered (additional findings). Dealing with additional genetic findings always poses a challenge when carrying out the informed consent process prior to genetic testing. This applies, in particular, to additional genetic findings in minors, since in this case the parents or other legal guardians make the decision regarding the handling of additional genetic findings on behalf of those minors. Such proxy decisions pose a particular ethical challenge if the implications of this decision become relevant only in the child's adulthood, e.g., when a predisposition to a late-onset disease is identified. Thus far, no general recommendations on guidelines for an adequate informed consent process regarding the return of additional genetic findings in minors have been developed. With the present statement, the Heidelberg Group EURAT aims to close this gap and provide recommendations for the handling of additional genetic findings in minors. These recommendations are based on detailed legal and ethical analyses and explicitly address establishing an adequate informed consent process that attempts to minimize the likelihood of potential conflicts when returning additional genetic findings in minors. In addition to the recommendations, the EURAT Group provides an information brochure, as well as text modules for the informed consent process regarding the handling of additional genetic findings in minors.
000286228 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000286228 588__ $$aDataset connected to DataCite
000286228 7001_ $$aCornelius, Kai$$b1
000286228 7001_ $$0P:(DE-He78)599c5b5d9ad07235476360a5838508d9$$aSchickhardt, Christoph$$b2$$udkfz
000286228 7001_ $$aDikow, Nicola$$b3
000286228 7001_ $$aWinkler, Eva$$b4
000286228 7001_ $$0P:(DE-He78)fc949170377b58098e46141d95c72661$$aBrors, Benedikt$$b5$$udkfz
000286228 7001_ $$0P:(DE-He78)f0144d171d26dbedb67c9db1df35629d$$aFröhling, Stefan$$b6$$udkfz
000286228 7001_ $$0P:(DE-He78)0fb05e0a459f26d2e2796de58d6f1dff$$aGreulich-Bode, Karin$$b7$$udkfz
000286228 7001_ $$aIdler, Irina$$b8
000286228 7001_ $$0P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c$$aLichter, Peter$$b9$$udkfz
000286228 7001_ $$0P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f$$aMilde, Till$$b10$$udkfz
000286228 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan$$b11$$udkfz
000286228 7001_ $$aSchaaf, Christian$$b12
000286228 7001_ $$0P:(DE-He78)f6bebe05e7a748d3cbf9f59659567d52$$aWiemann, Stefan$$b13$$udkfz
000286228 773__ $$a10.11588/FMK.2023.23.100566
000286228 909CO $$ooai:inrepo02.dkfz.de:286228$$pVDB
000286228 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)85715ba619c4d7ffa8455b3320ffe1ed$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000286228 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)599c5b5d9ad07235476360a5838508d9$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000286228 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fc949170377b58098e46141d95c72661$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000286228 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f0144d171d26dbedb67c9db1df35629d$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000286228 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0fb05e0a459f26d2e2796de58d6f1dff$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000286228 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000286228 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000286228 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000286228 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f6bebe05e7a748d3cbf9f59659567d52$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000286228 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000286228 9141_ $$y2023
000286228 9201_ $$0I:(DE-He78)D120-20160331$$kD120$$lD120 Angewandte Tumor-Immunität$$x0
000286228 9201_ $$0I:(DE-He78)B330-20160331$$kB330$$lAngewandte Bioinformatik$$x1
000286228 9201_ $$0I:(DE-He78)B340-20160331$$kB340$$lTranslationale Medizinische Onkologie$$x2
000286228 9201_ $$0I:(DE-He78)M100-20160331$$kM100$$lM100 Krebsinformationsdienst$$x3
000286228 9201_ $$0I:(DE-He78)B060-20160331$$kB060$$lB060 Molekulare Genetik$$x4
000286228 9201_ $$0I:(DE-He78)B310-20160331$$kB310$$lKKE Pädiatrische Onkologie$$x5
000286228 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x6
000286228 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x7
000286228 9201_ $$0I:(DE-He78)B050-20160331$$kB050$$lB050 Molekulare Genomanalyse$$x8
000286228 980__ $$abook
000286228 980__ $$aVDB
000286228 980__ $$aproc
000286228 980__ $$aI:(DE-He78)D120-20160331
000286228 980__ $$aI:(DE-He78)B330-20160331
000286228 980__ $$aI:(DE-He78)B340-20160331
000286228 980__ $$aI:(DE-He78)M100-20160331
000286228 980__ $$aI:(DE-He78)B060-20160331
000286228 980__ $$aI:(DE-He78)B310-20160331
000286228 980__ $$aI:(DE-He78)B062-20160331
000286228 980__ $$aI:(DE-He78)HD01-20160331
000286228 980__ $$aI:(DE-He78)B050-20160331
000286228 980__ $$aUNRESTRICTED